LUMOS PHARMA, INC. (LUMO)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch LUMO
See up to 3 months of LUMO. The 7-day demo opens the 1M and 3M ranges and puts LUMO on your watchlist.
Start 7-day demoLatest LUMO insider trades
About LUMOS PHARMA, INC. (LUMO)
The SEC lists LUMOS PHARMA, INC. under CIK 0001126234, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
LUMO Form 4 activity by transaction type, last 90 days
No Form 4 activity for LUMO in the last 90 days.
LUMO insider transactions (Form 4)
9212 Form 4 filings on record, the earliest from Dec 13, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard J. Hawkins - Officer | Derivative | Common Stock | 753,093 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Common Stock | 4,469 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 19,624 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 35,400 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 35,400 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 135,000 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 35,400 | - | - | |
| Richard J. Hawkins - Officer | Derivative | Stock Option (Right to Buy) | 28,475 | - | - | |
| Lota S. Zoth - Director | Derivative | Common Stock | 2,187 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 5,684 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 2,777 | - | - | |
| Lota S. Zoth - Director | Derivative | Stock Option (Right to Buy) | 5,324 | - | - | |
| John C. McKew - Officer | Derivative | Common Stock | 13,153 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 16,000 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 16,000 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 6,541 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 9,583 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 81,690 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 65,000 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 14,000 | - | - | |
| John C. McKew - Officer | Derivative | Stock Option (Right to Buy) | 33,175 | - | - | |
| Chad Allen Johnson - Director | Derivative | Common Stock | 1,076 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 5,684 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 2,777 | - | - | |
| Chad Allen Johnson - Director | Derivative | Stock Option (Right to Buy) | 4,227 | - | - | |
| Es-Johansson An van - Director | Derivative | Common Stock | 1,100 | - | - | |
| Es-Johansson An van - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Es-Johansson An van - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Es-Johansson An van - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Es-Johansson An van - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - | |
| Es-Johansson An van - Director | Derivative | Stock Option (Right to Buy) | 5,729 | - | - | |
| Thomas A. Raffin - Director | Derivative | Common Stock | 9,406 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 5,684 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 2,777 | - | - | |
| Thomas A. Raffin - Director | Derivative | Stock Option (Right to Buy) | 10,439 | - | - | |
| Pisit Duke Pitukcheewanont - Officer | Derivative | Common Stock | 16,836 | - | - | |
| Pisit Duke Pitukcheewanont - Officer | Derivative | Stock Option (Right to Buy) | 3,333 | - | - | |
| Pisit Duke Pitukcheewanont - Officer | Derivative | Stock Option (Right to Buy) | 25,500 | - | - | |
| Pisit Duke Pitukcheewanont - Officer | Derivative | Stock Option (Right to Buy) | 41,500 | - | - | |
| Pisit Duke Pitukcheewanont - Officer | Derivative | Stock Option (Right to Buy) | 29,750 | - | - | |
| Kevin M. Lalande - Director | Derivative | Common Stock | 1,076 | - | - | |
| Kevin M. Lalande - Director | Derivative | Common Stock | 730,446 | - | - | |
| Kevin M. Lalande - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Kevin M. Lalande - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Kevin M. Lalande - Director | Derivative | Stock Option (Right to Buy) | 5,684 | - | - | |
| Kevin M. Lalande - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Kevin M. Lalande - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - | |
| Aaron Schuchart - Officer | Derivative | Common Stock | 8,179 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 45,000 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 7,805 | - | - | |
| Aaron Schuchart - Officer | Derivative | Stock Option (Right to Buy) | 8,500 | - | - | |
| Bradley J. Powers - Officer | Derivative | Common Stock | 6,307 | - | - | |
| Bradley J. Powers - Officer | Derivative | Common Stock | 27 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 11,000 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 11,000 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 11,000 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 1,887 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 7,407 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 10,625 | - | - | |
| Bradley J. Powers - Officer | Derivative | Stock Option (Right to Buy) | 5,554 | - | - | |
| Lori D. Lawley - Officer | Derivative | Common Stock | 12,284 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 21,250 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 1,282 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 4,628 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 10,625 | - | - | |
| Lori D. Lawley - Officer | Derivative | Stock Option (Right to Buy) | 2,776 | - | - | |
| Joseph S. McCracken - Director | Derivative | Common Stock | 15,721 | - | - | |
| Joseph S. McCracken - Director | Derivative | Stock Option (Right to Buy) | 3,345 | - | - | |
| Joseph S. McCracken - Director | Derivative | Stock Option (Right to Buy) | 3,328 | - | - | |
| Joseph S. McCracken - Director | Derivative | Stock Option (Right to Buy) | 5,684 | - | - | |
| Joseph S. McCracken - Director | Derivative | Stock Option (Right to Buy) | 3,431 | - | - | |
| Joseph S. McCracken - Director | Derivative | Stock Option (Right to Buy) | 2,910 | - | - |
LUMO insider trading FAQ
What is the latest insider trade for LUMO?
LUMOS PHARMA, INC. (LUMO) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-13. The full record for LUMO runs to 12 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LUMO stock?
No insider purchases of LUMO were filed in the last 90 days.
How many insiders are selling LUMO stock?
No insider sales of LUMO were filed in the last 90 days.
Where can I see LUMO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LUMO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard J. Hawkins view on EDGAR
- - Lota S. Zoth view on EDGAR
- - John C. McKew view on EDGAR
- - Chad Allen Johnson view on EDGAR
- - Es-Johansson An van view on EDGAR
- - Thomas A. Raffin view on EDGAR
- - Pisit Duke Pitukcheewanont view on EDGAR
- - Kevin M. Lalande view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LUMO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LUMO with a 7-day demo
- LUMO on your watchlist
- Every LUMO Form 4 filing on record
- Up to 3 months of LUMO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
